Deja Williams is a member of the firm’s Health Care Alignment & Organization practice, where she supports health systems, hospitals and provider organizations on regulatory compliance, operational strategy and physician alignment matters. She brings prior experience as a Polsinelli Healthcare Law Fellow, where she advised on legal issues involving hospital operations, patient care and allied health professions.

In addition to her legal experience, Deja served as a clinical assistant professor at the University of Montana, teaching graduate-level courses in social work practice, policy and community systems. She also completed a social work internship with Michigan Medicine’s adult inpatient psychiatric unit, supporting patient discharge planning and multidisciplinary care coordination. Drawing on her clinical and academic background, Deja brings a grounded approach to her work with health care clients.

Education

  • The George Washington University Law School (J.D., 2023)
    • Richard C. Lewis Jr. Memorial Award recipient
  • University of Michigan School of Social Work (M.S.W., 2018)
    • Spring Arbor University (B.S., 2017)

      Bar Admission

      • Kansas
      • Missouri

      Professional Affiliations

      • American Health Law Association
      Publications
      All Publications
      2026 340B Program Update – 340B Rebate Model RFI Comments Due and Manufacturers Continue Restricting 340B Pricing
      Key Takeaways HRSA has extended the deadline for comments on its proposed 340B rebate model pilot program to April 20, 2026. Covered entities have a limited window to submit detailed feedback on how the model would affect operations and patient care. The proposed rebate model and new manufacturer data submission policies increase administrative burden and create risk of pricing denials and cash flow disruption. These changes could significantly expand compliance obligations and force providers into frequent disputes to recover 340B savings. Covered entities should submit detailed RFI comments and actively monitor 340B pricing access and denials. Providers should also begin tracking data, documenting losses and preparing for potential ADR filings and manufacturer engagement. The 340B program is experiencing rapid changes that could have a
      Read More
      Moratorium on New DME Medicaid Provider Enrollment in Florida
      Key Takeaways: Florida’s Agency for Healthcare Administration (AHCA) has implemented a six-month moratorium on the enrollment of new Durable Medical Equipment (DME) providers, effective March 20, 2026. The moratorium applies statewide and affects all new DME provider applications submitted after the effective date. Applications submitted prior to March 20 will continue to be processed. Pharmacies, hospitals and providers furnishing DME as a secondary service are not subject to the moratorium and may continue with enrollment. This action follows a similar federal moratorium from the Centers for Medicare & Medicaid Services (CMS) aimed at curbing fraud and protecting taxpayer resources, as Florida has been identified as a high-risk area for DME-related fraud. Effective March 20, 2026, Florida’s AHCA has implemented a statewide moratorium on the enrollment
      Read More